Stocks
Teva Pharmaceutical Industries (TEVA) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 7.57% | -12.6% | 27.8% | -5.86% | 27.3% | 12.1% | ||
| Changes by years, y/y, % | -9pp | -20pp | +40pp | -34pp | +33pp | +10.3% | |||
Teva Pharmaceutical Industries. EBITDA margin, %
Teva Pharmaceutical Industries. EBITDA margin, changes, pp
Teva Pharmaceutical Industries (TEVA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 16.9% | 34.0% | 1.17% | 6.10% | 4.85% | 12.1% | |
| Changes by years, y/y, % | -10pp | +7pp | -21pp | -19pp | -22pp | |||
| Changes by quarters, q/q, % | -10pp | +17pp | -33pp | +5pp | -1pp | |||
